
Cann Group (ASX:CAN) is an Australian medical cannabis company with operations in Australia, Europe, and North America. The company's core business is the cultivation, manufacture, and distribution of medical cannabis products. Cann Group also has a number of research and development projects underway, including the development of new medical cannabis products and the use of cannabis for the treatment of specific medical conditions. Cann Group aims to develop new medical cannabis products: Cann Group is committed to the development of new medical cannabis products.